Gemini Therapeutics logo
Gemini Therapeutics GMTX
$ 1.56 0.97%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Gemini Therapeutics Cash Flow 2011-2024 | GMTX

Annual Cash Flow Gemini Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-73.5 M -42.3 M -27.5 M -32.7 M - - - - - - - - -

Depreciation & Amortization

100 K 89 K 32 K 322 K - - - - - - - - -

Accounts Payables

12.6 M 16.2 M 2.56 M 4.65 K - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow Gemini Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - - - - -35.5 M - -29.8 M -25.8 M -13.7 M - -47 M -30.9 M -15 M - -191 K -16.9 M -9.88 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

- - - - - 25 K - - - 18 K - 185 K 127 K 65 K - 235 K 155 K 77 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

3.55 M 4.75 M 12.6 M 8.5 M 5.21 M 5.64 M 16.2 M 1.14 M 1.62 M 5.11 M 2.95 M 939 K 1.49 M 3.56 M 2.38 M 2.38 M 2.38 M 2.38 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency